Genprex, Inc. GNPX
2.09 USD +0.03 (+1.46%)
At closeNov 10, 2026, 5:22 PM EST
2.15 +0.06 +2.81%
After hours · Nov 10, 5:22 PM ET
2.07 Day range 2.20
1.71 52-week range 110.00
- YTD
- -94.57%
- 1 year
- -97.63%
News
prnewswire.com Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator of Resilience to Aging-Associated Stress Whole-Blood Translational Analysis from Clinical Trial Patients Link TUSC2 to Mitochondrial Adaptation, Autophagy, and Protein Quality Control Expands Upon Existing REQORSA Research, Supporting…
prnewswire.com Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer Research to be Presented at the 2026 EORTC-NCI-AACR Symposium Links TROP2 Expression to Treatment Response and Explores its Role in Treatment Sensitivity Findings Suggest Low TROP2 Expression is…
benzinga.com Genprex Highlights New Peer-Reviewed Research In Mice Identifying Important Role For TUSC2 Tumor Suppressor Gene In Maintaining Cellular Processes Associated With Healthy Brain Aging Collaborators publish new peer-reviewed study identifying sex-specific effects of TUSC2 loss on mitochondrial function, protein homeostasis, and synaptic pathways, alongside molecular similarities…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Silexion Therapeutics (NASDAQ:SLXN) shares moved upwards by 11.0% to $0.17 during Friday's after-market session. The company's market cap stands at $2.4 million. Lexaria Bioscience…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 27.1% to $0.31 during Monday's after-market session. The market value of their outstanding shares is at $1.4 million. Chemomab Therapeutics…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after-market session. The company's market cap stands at $1.7 million. The company's, Q2 earnings came out…- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday's regular session. The market value of their outstanding shares is at $2.0 million. SL Science Holding…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 million. Supernus…
benzinga.com Genprex Partners With Roche Diagnostics To Validate Biomarkers For Patient Selection In Clinical Trials For Non-Small Cell Lung Cancer Building on promising preclinical and clinical data, this collaboration intends to refine patient identification using TROP2 as a biomarker. Genprex's initial research demonstrated that high TROP2…
benzinga.com Genprex Receives Notice Of Allowance From CIPO For Patent Covering Use Of Reqorsa Gene Therapy In Combination With Either PD-1 Or PD-L1 Antibodies For Treatment Of Lung Cancer Patent Covers Acclaim-3 Clinical Trials Combining REQORSA Gene Therapy with Genentech, Inc.'s Tecentriq®AUSTIN, Texas, June 22, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company")- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Genprex Files For Mixed Shelf Of Up To $250M https://www.sec.gov/Archives/edgar/data/1595248/000143774926019760/gnpx20260518_s3.htm- benzinga.com Genprex Showcases Positive Preclinical Data On Its Diabetes Gene Therapy Drug Candidate At 2026 American Society Of Gene And Cell Therapy Annual Meeting Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced…
benzinga.com Genprex Q1 EPS $(0.64) Up From $(13.00) YoY Genprex (NASDAQ:GNPX) reported quarterly losses of $(0.64) per share. This is a 95.08 percent increase over losses of $(13.00) per share from the same period last year.
benzinga.com Top 3 Health Care Stocks That Are Set To Fly In Q2 The health care sector has oversold stocks with RSI below 30, presenting an opportunity for traders to buy undervalued companies.
benzinga.com Israel Patent Office Grants Genprex Patent Covering Use Of Reqorsa Gene Therapy In Combination With PD-1 Antibodies For Treatment Of Cancer Strengthens Patent Estate and Expands Protection in Another Target MarketAUSTIN, Texas, April 30, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ:GNPX), a clinical-stage gene…
benzinga.com Genprex Research Collaborators Presents Preclinical Data From Studies Of Lead Drug Candidate, Reqorsa Gene Therapy For Treatment Of Lung Cancer At 2026 AACR Annual Meeting TROP2 and PTEN Biomarkers May Predict Patient Response to Reqorsa® Gene TherapyREQORSA Induced Apoptosis and Decreased Tumor Volume in ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer Cell…
benzinga.com Top Ranking Stock Picker From Congress Is Back Buying Small Cap Stocks Again: Here Are The Tickers A Congress member continues to buy small cap stocks. Here's the latest names added to his investment portfolio in March 2026.
benzinga.com Congressman Who Bought Small-Cap Stocks In 2025 Is Back With New 2026 Pick: Here's What He's Buying A member of Congress is buying stock in two small cap companies in 2026. Here's the stocks and why investors should be watching.- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com Genprex Says Japanese Patent Office Issues Favourable Appeal Decision To Grant Patent Claiming Use Of Reqorsa Gene Therapy In Combination With PD-L1 Antibodies To Treat Cancer Japanese Patent Covers Acclaim-3 Clinical Trial Combining REQORSA Gene Therapy with Genentech, Inc.'sTecentriq®
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Congressman Who Was Top 2025 Stock Picker Buys Shares Of $5M Company You've Never Heard Of A Republican U.S. Representative made multiple trades in 2025, including Cracker Barrel and a little-known gene therapy firm.- benzinga.com Genprex Announces Clinical Program Update On GPX-002 Diabetes Gene Therapy Candidate Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Genprex Announces Preliminary in Vivo Preclinical Proof-of-concept Data for GPX-002 Diabetes Gene Therapy Drug Candidate, in a Non-human Primate Model and Mouse Model of Type 2 Diabetes Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human PrimatesGPX-002 Rejuvenated Exhausted Beta Cells and Normalized Glucose…
benzinga.com Move Over, Pelosi: This Congress Member Posted 2025's Best Market Return With A 52% Gain The list of the top 10 members of Congress for 2025 investment portfolio gains. Where did Marjorie Taylor Greene rank and how close was Nancy Pelosi to the Top 10?- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Congressman Buys Shares Of Small Cap Lift Truck Company You've Probably Never Heard Of A congressman bought shares of a small cap company recently. Here's a look at the stock and why it's drawing attention.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Netflix Posts Downbeat Earnings, Joins Aveanna Healthcare, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why J.B. Hunt Transport Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com Gold Gains Over 1%; Abbott Shares Fall After Q3 Results - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com S&P 500 Gains 1%; Bank of America Posts Upbeat Earnings - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Veritone Shares Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session